Contribute
España
Italia
대한민국
日本
Français
Benzinga
Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
766.880.43%
QQQ
716.430.35%
BTC/USD
78173.001.1598%
DIA
529.260.9%
GLD
403.240.87%
TLT
82.420.26%

Calidi Biotherapeutics Inc (CLDI) Stock Price, Quote, News & History

CLDIAMEX
Trade with Public
Trade with Public
$1.37
-0.015-1.08%
Last update: Sep 8, 9:35 AM
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareStock Report

Calidi Biotherapeutics (CLDI) Stock Price, Quote, News & History | Benzinga

Key Statistics

Open
-
Close
-
Volume / Avg.
10.19K / 289.82K
Day Range
- - -
52 Wk Range
1.25 - 27.84
Market Cap
$3.54M
P/E Ratio
-
Dividend Yield
-
Exchange
AMEX
RSI
40
Short Interest
12.22%
Days to Cover
1.55

Recent Calidi Biotherapeutics Inc News

Why Crown Holdings Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket

Crown Holdings Inc (CCK) stock gained 16.4% in pre-market trading after reporting strong Q2 results and raising its FY26 EPS guidance. Other gaining stocks include SLGB, HIHO, WNW, CHNR, RDGT, ULBI, GLMD, SMTK, and PRTA while LBGJ is down 45.1%.
Avi Kapoor

Why Bed Bath & Beyond Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarket

Shares of Bed Bath & Beyond (BBBY) rose 23.4% in pre-market trading after beating revenue estimates. KIDZ, CLDI, DRCT, PFSA, KFRC, MLEC, SANM, SEI, DT are also up while VISN, ERAS, AREB, and YAAS are down.
Avi Kapoor

Crude Oil Jumps Over 12%; US Retail Sales Fall In January

U.S. stocks fall on Friday with the S&P 500 and NASDAQ dropping around 1%. Energy shares rise while financial stocks dip. Retail sales decline and job growth slows in February.
Avi Kapoor

Nasdaq Down Over 300 Points; US Economy Loses 92,000 Jobs In February

Stocks down, Nasdaq falls 300+ points. Dow down 1.62%, Nasdaq down 1.47%, S&P 500 down 1.38%. Energy shares rise, financial stocks dip. US economy loses 92K nonfarm payrolls in Feb.
Avi Kapoor

Calidi Biotherapeutics (CLDI) Stock Plunges 35% After Hours — Here's Why

Calidi Biotherapeutics shares plunged after hours following a public offering announcement, trading near their 52-week low.
Mohd Haider

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-17.75M
Investing Cash Flow (TTM)
-144.00K
Financing Cash Flow (TTM)
16.81M
Free Cash Flow (TTM)
-17.85M
Capital Expenditure (TTM)
-94.00K
Net Change in Cash (TTM)
-1.09M

Analyst Rating and Forecast

12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$1.45M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
1.14
Earnings Yield % (TTM)
-2674.37%
Earnings Yield % (FWD)
-
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$1.21

Company Debt

Total Debt
$600.00K
LT Debt
$600.00K
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-$522.00K
Total Cash
$4.07M
Debt to Equity
0.62
Issuance of Debt (TTM)
-$522.00K
Repayment of Debt (TTM)
-$522.00K

Key Statistics

Open
-
Close
-
Volume / Avg.
10.19K / 289.82K
Day Range
- - -
52 Wk Range
1.25 - 27.84
Market Cap
$3.54M
P/E Ratio
-
Dividend Yield
-
Exchange
AMEX
RSI
40
Short Interest
12.22%
Days to Cover
1.55

About

Sector
Health Care
Industry
Biotechnology
Calidi Biotherapeutics Inc is a biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease. The company's proprietary RedTail platform features an engineered envel...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Calidi Biotherapeutics (CLDI) stock?

A

You can purchase shares of Calidi Biotherapeutics (AMEX:CLDI) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Calidi Biotherapeutics (CLDI) competitors?

Q

What is the forecast, or price target, for Calidi Biotherapeutics (CLDI) stock?

A

Calidi Biotherapeutics has a consensus price target of $1.67.

Q

What is the current price for Calidi Biotherapeutics (CLDI)?

A

The stock price for Calidi Biotherapeutics (AMEX: CLDI) is $1.37 last updated September 8, 2026 at 9:35 AM EDT.

Q

Does Calidi Biotherapeutics (CLDI) pay a dividend?

A

There are no upcoming dividends for Calidi Biotherapeutics.

Q

When is Calidi Biotherapeutics (AMEX:CLDI) reporting earnings?

A

Calidi Biotherapeutics does not have any upcoming earnings scheduled.

Q

Is Calidi Biotherapeutics (CLDI) going to split?

A

There is no upcoming split for Calidi Biotherapeutics.

Q

What sector and industry does Calidi Biotherapeutics (CLDI) operate in?

A

Calidi Biotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved